University of Washington
Hematology and Oncology fellowship · Seattle, WA · Program website
This program's roster hasn't been collected yet, so there's no list of its own faculty and papers. Below is University of Washington's research in hematology and oncology, which the program shares with other departments and affiliated hospitals.
About University of Washingtoninstitution-wide hematology and oncology research
Hematology and Oncology publications from University of Washington and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
572
works per year
5th of 74 hematology and oncology fellowship programs
+16.1%
2-year growth
28th of 74 hematology and oncology fellowship programs
32.3%
in top 10% of field (works before 2025)
9th of 72 hematology and oncology fellowship programs
53.1%
cited above world average
4th of 72 hematology and oncology fellowship programs
Works per year · * 2026 so far
Oncology · 1,775Hematology · 1,022
Hematology and Oncology research topics at University of Washington
Papers in the window; each links to the list on OpenAlex.
- Hematopoietic Stem Cell Transplantation 324
- CAR-T cell therapy research 317
- Acute Myeloid Leukemia Research 195
- Cancer Immunotherapy and Biomarkers 187
- Cancer survivorship and care 159
- Global Cancer Incidence and Screening 134
- Colorectal Cancer Screening and Detection 117
- Multiple Myeloma Research and Treatments 104
Most cited at University of Washington since 2024
All hematology and oncology papers there on OpenAlex
- The global, regional, and national burden of cancer, 1990–2023, with forecasts to 2050: a systematic analysis for the Global Burden of Disease Study 2023Lisa M Force et al. · The Lancet · 2025 · PubMed · cited 498
- Global Disparities of Cancer and Its Projected Burden in 2050Habtamu Mellie Bizuayehu et al. · JAMA Network Open · 2024 · PubMed · cited 457
- A Cell-free DNA Blood-Based Test for Colorectal Cancer ScreeningDaniel C. Chung et al. · New England Journal of Medicine · 2024 · PubMed · cited 452
- Ribociclib plus Endocrine Therapy in Early Breast CancerDennis J. Slamon et al. · New England Journal of Medicine · 2024 · PubMed · cited 432
- Afamitresgene autoleucel for advanced synovial sarcoma and myxoid round cell liposarcoma (SPEARHEAD-1): an international, open-label, phase 2 trialSandra P. D’Angelo et al. · The Lancet · 2024 · PubMed · cited 319
- Genetic risk classification for adults with AML receiving less-intensive therapies: the 2024 ELN recommendationsHartmut Döhner et al. · Blood · 2024 · PubMed · cited 274
- Blinatumomab in Standard-Risk B-Cell Acute Lymphoblastic Leukemia in ChildrenSumit Gupta et al. · New England Journal of Medicine · 2024 · PubMed · cited 240
- JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphomaJaroslav Žák et al. · Science · 2024 · PubMed · cited 204
- Intracerebroventricular B7-H3-targeting CAR T cells for diffuse intrinsic pontine glioma: a phase 1 trialNicholas Alexander Vitanza et al. · Nature Medicine · 2025 · PubMed · cited 183
- Trastuzumab deruxtecan versus trastuzumab emtansine in HER2-positive metastatic breast cancer: long-term survival analysis of the DESTINY-Breast03 trialJavier Cortés et al. · Nature Medicine · 2024 · PubMed · cited 181